On Wednesday, the European Medicines Agency (EMA) gave the go-ahead to bring Moderna’s vaccine to market, which would also be in comparison to the Pfizer/BioNTech vaccine, which has been the only one delivered in the European Union so far. Moderna Inc. (MRNA) increased to $116.26, up +6.48 percent. On the day, the European Medicines Agency (EMA) approved the U.S. laboratory’s new coronavirus vaccine for persons over the age of 18, a vaccine that had already gained the requisite approval in the United States.
Having previously approved Pfizer/BioNTech, the EMA has thus validated the vaccine. It is estimated that the vaccine of Moderna is more than 94 percent effective. It is a two-dose, easier-to-keep vaccine than Pfizer’s. To monitor the rebound of the pandemic when enforcing their vaccine campaigns, most European countries, including the United Kingdom, Germany, and France, have recently expanded or intensified their restriction and/or lockdown measures.
In the face of a potential Democratic win in the Senate, where two seats are at stake in Georgia, which could provide power to the Biden clan and make for greater business regulation, the internet, e-commerce, and other U.S. tech giants have been left behind. Apple Inc. (AAPL) decreased by -3.37% to $126.6; Alphabet Inc. (GOOGL) was down to $1722.88, down -0.99 percent; Facebook, Inc. (FB) dropped -2.83% to $263.31; Microsoft Corporation (MSFT) decreased by -2.59% to $212.25 while Amazon.com, Inc. (AMZN) dropped -2.49% to $3138.38.
In the Senate, the possibility of a Political win promotes banking stocks, but also “green” stocks that will benefit from legislation favorable to new energy sources. Thus, the investors looked for solar players and won ground. SunPower Corporation (SPWR) rose to $29.73, up +20.17 percent; First Solar Inc. (FSLR) increased to $99.69 after a rise of +8.17 percent; whereas Sunrun Inc. (RUN) increased to $85.17 after surging +16.53 percent on the day.
Tesla, Inc. (TSLA) increased to $755.98, up +2.84 percent. The recommendation is backed by Morgan Stanley, with the analyst raising its price target on the valuation of the electric car pioneer to $810 from $540 previously. The firm welcomes, in particular, the good deliveries for the fourth quarter of Elon Musk’s company. On Wall Street, the goal is the biggest.